Development and Validation of a Japanese Version of the Emotion Regulation Questionnaire for Children and Adolescents
Received 4 April 2019
Accepted for publication 20 December 2019
Published 21 January 2020 Volume 2020:16 Pages 209—219
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Taro Kishi
Hikari Namatame, 1, 2 Hiroko Fujisato, 2 Masaya Ito, 2 Yoko Sawamiya 1
1Faculty of Human Sciences, University of Tsukuba, Tsukuba City, Ibaraki, Japan; 2National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Kodaira City, Tokyo, Japan
Correspondence: Hikari Namatame
Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan
Purpose: We developed a Japanese version of the Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA) and examined its reliability and validity across three studies.
Patients and Methods: In Study 1, the Japanese version of ERQ-CA was developed and administered to 389 children aged 8– 12 years. In Study 2, the questionnaire was administered to 1738 adolescents aged 12– 18 years. In Study 3, utilizing a sample of 1300 children and adolescents, the test was administered twice over a period of four weeks in order to assess test–retest reliability.
Results: In Study 1, the Japanese version of ERQ-CA showed the same factor structure as the original version, along with good internal consistency reliability and acceptable construct validity. In Study 2, the questionnaire’s factor structure, internal consistency reliability, and construct validity were again confirmed. Finally, in Study 3, measurement invariance was tested across distinct age groups (8– 11, 12– 15, and 16– 18 years), and the questionnaire had good test–retest reliability over a period of four weeks.
Conclusion: The Japanese version of the ERQ-CA had good reliability and validity.
Keywords: adolescents, children, emotion regulation, Japan, reliability validity
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]